Ceribell, Inc. (CBLL)

↓ Download CSV

CIK 0001861107 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Ceribell, Inc. reported revenue of $89.06M, up 36.1% from the prior year. The company ran a net loss, with a net margin of -60.0% and a gross margin of 87.9%. It held $195.80M in total assets against $40.47M in total liabilities.

Key ratios (FY2025)

87.9%
Gross margin
-65.6%
Operating margin
-60.0%
Net margin
-34.4%
Return on equity
+36.1%
Revenue growth (YoY)
Metric (FY)2025202420232022
Revenue$89.06M$65.44M$45.23M
Cost of Revenue$10.79M$8.69M$7.06M
Gross Profit$78.27M$56.75M$38.16M
Operating Income-$58.40M-$39.71M-$30.04M
Net Income-$53.41M-$40.45M-$29.46M
EPS (Diluted)$-1.46$-3.39$-5.56
Total Assets$195.80M$225.41M$58.92M
Total Liabilities$40.47M$34.25M$23.76M
Shareholders' Equity$155.34M$191.16M-$112.25M-$86.40M
Cash & Equivalents$40.48M$194.37M$34.49M
Operating Cash Flow-$40.81M-$35.04M-$29.16M
Capital Expenditures$767.0K$1.34M$983.0K
Shares Outstanding37.49M35.85M5.43M